Abstract

Background: Juvenile Nasopharyngeal Angiofibroma (JNA) are benign, rare and highly vascular tumors of nose and para nasal sinuses seen only in post pubertal males. Aim: To study surgical prognostic factors for JNA. Objectives: To study the effect of presenting features namely blood supply, blood loss, tumor grading, steroid therapy and age of presentation on surgical prognosis. Material: Presenting features and surgical outcomes of all 4 operated JNA patients were compared from the Departmental records. Result: Unilateral blood supply, Lesser pre-operative blood loss, lesser grade tumor, longer steroid therapy and more age at presentation have better surgical outcome. Conclusion: Although benign and rare to encounter, their diagnosis and management is a challenge owing to their highly vascular nature and their blood supply directly from or from main branches of carotid arteries. Here, we present four cases of successful management of JNA with detailed discussion of surgical prognostic factors of the rare tumor

• 1.   Tork C.A., Simpson D.L. Nasopharyngeal Angiofibroma. [Updated 2022 Jun 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/ NBK545240/
• 2.   Safadi A., Schreiber A., Fliss D.M., Nicolai P. Juvenile Angiofibroma: Current Management Strategies. J Neurol Surg B Skull Base. 2018 Feb; 79(1):21-30. doi: 10.1055/s-0037-1615810. Epub 2018 Jan. 18. PMID: 29404237; PMCID: PMC5796815.
• 3.   Butler C.R., Scholfield D.W., Madani G., Sandison A., Clarke P.M. Current Management and Controversies of Juvenile Angiofibromas. Int J. Head Neck Surg 2018; 9(1):32-37.
• 4.   Makhasana J.A., Kulkarni MA, Vaze S, Shroff AS. Juvenile nasopharyngeal angiofibroma. J Oral Maxillofac Pathol. 2016 May-Aug;20(2):330.
• 5.   Alshaikh N.A., Eleftheriadou A. Juvenile nasopharyngeal angiofibroma staging: An overview. Ear Nose Throat J. 2015 Jun; 94(6):E12-22.
• 6.   Allensworth J.J., Troob S.H., Lanciault C., Andersen P.E. High-grade malignant transformation of a radiation-naïve nasopharyngeal angiofibroma. Head Neck. 2016 Apr; 38 Suppl 1:E2425-7
• 7.   Park C.K., Kim D.G., Paek S.H., Chung H.T., Jung H.W. Recurrent juvenile nasopharyngeal angiofibroma treated with gamma knife surgery. J. Korean Med Sci. 2006 Aug; 21(4):773-7.
• 8.   Overdevest J.B., Amans M.R., Zaki P., Pletcher S.D., El-Sayed I.H. Patterns of vascularization and surgical morbidity in juvenile nasopharyngeal angiofibroma: A case series, systematic review, and meta-analysis. Head Neck. 2018 Feb; 40(2):428-443.
• 9.   Wai Lup Wong and Bal Sanghera. Recent advances in technology. In John C Watkinson and Raymond W Clarke. Scott Brown’s Otorhinolaryngology Head & Neck Surgery. 8th ed. New York: CRC Press;2018.p541-58.
• 10.   Andrews J.C., Fisch U., Valavanis A., Aeppli U., Makek M.S. The surgical management of extensive nasopharyngeal angiofibromas with the infratemporal fossa approach. Laryngoscope 1989; 99:429-37.
• 11.   James V. Byrne. Interventional Techniques. In John C. Watkinson and Raymond W. Clarke. Scott Brown’s Otorhinolaryngology Head & Neck Surgery. 8th ed. New York: CRC Press; 2018. p 569-80.
• 12.   Mehan R., Rupa V., Lukka V.K., Ahmed M., Moses V., Shyam Kumar N.K. Association between vascular supply, stage and tumour size of juvenile nasopharyngeal angiofibroma. Eur Arch Otorhinolaryngol. 2016 Dec;273(12):4295-4303.

Data Sharing Statement

Funding